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Abstract
Myocardial ischemia is often associated to aortic valve stenosis in the elderly. Aim of this study was to evaluate the
impact on survival and quality of life of CABG associated to aortic valve replacement in the septuagenarians and
octogenarians.
Between January 1991 and January 2010, 520 patients ageing > 70 years underwent aortic valve replacement with
a mechanical prosthesis in two Institutions. They were divided into 2 groups: Group A included 406 patients
undergoing isolated aortic valve replacement; Group B 114 patients receiving aortic valve replacement and CABG.
A comparative analysis of long-term survival and quality of life (SF-36 test) was performed.
Mean age was 74.2 ± 3.6 years (74.3 ± 3.6 in Group A, 74 ± 3.3 in Group B; p = 0.33). Hospital mortality was 9.5%
(46 patients). Twenty-nine (7.8%) in Group A and 17 in Group B (15.2%)(p = 0.019). Actuarial survival was 88.5% ±
0.015 at 1 year, 81.9% ± 0.02 at 5 years, 76.6% ± 0.032 at 10 and 57.3 ± 0.1 at 15 years. Ten-year survival was 77%
± 0.034 in Group A and 77.8% ± 0.045 in Group B (p = 0.2). Multivariate analysis did not reveal associated CABG as
a predictor of long term mortality. The scores obtained in the SF-36 test were similar in the two groups and
significantly higher than those of the general population matched for country, age and sex (p < 0.001 in all
domains).
Associated CABG determines a significant increase of hospital mortality in the elderly undergoing aortic valve
replacement. Survivors did not show differences in long-term outcome and quality of life according to the
presence of associated CABG.
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Introduction
Aortic valve replacement (AVR) is an accepted therapy
for septuagenarians or octogenarians affected by aortic
valve disease [1]. It has been demonstrated that isolated
AVR can be performed with a low operative mortality
rate in elderly patients, improves long-term survival and
quality of life (QOL) [2]. Calcified aortic stenosis is fre-
quently associated to coronary arteries diseases and
CABG is required during the AVR procedure. Aim of
the present study was to investigate the impact of
CABG associated to AVR on short and long term out-
come and quality of life in elderly patients.
Material and methods
Patient Population
Our Institutions Ethics Committee approved this study
and waived the need to obtain patient consent. Between
January 1991 and January 2010, 520 patients older than
70 years underwent consecutive AVR with mechanical
bileaflet prostheses; by policy, mechanical devices were
preferred at our Institutions in those years even in
elderly patients unless life-long anticoagulation was con-
traindicated. In our previous studies, the incidence of
anticoagulation-related complications was very low in
patients older than 70 years, who underwent mechanical
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strictly followed at our dedicated outpatient clinic [3-5].
In the light of our experience with mechanical valve
implantation and with the management of oral anticoa-
gulation in septuagenarians and octogenarians, asso-
ciated to high long-term survival rates in those series
showed, we prefer the use of bileaflet prostheses in
elderly, with the aim to avoid the risk of a possible reo-
peration in the eight and ninth decade of life for struc-
tural degeneration of bioprosthesis.
The study population was divided in group A (406
isolated AVR) and Group B (114 CABG associated to
AVR).
In-hospital Management
All patients underwent preoperative full cardiological
screening including trans-thoracic or trans-oesophageal
echocardiography and coronary angiography. All opera-
tions were performed by the same group of surgeons.
Cardiopulmonary bypass methods were uniform
throughout the study: systemic moderate hypothermia
was employed in all cases, along with myocardial protec-
tion through crystalloid hyperkaliemic cardioplegia infu-
sion into the aortic root in case of normal aortic valve
competence, or directly into the coronary ostia in case
of aortic valve regurgitation, associated to topical cool-
ing with cold saline.
Postoperative anticoagulant therapy was performed
with oral sodium warfarin in all patients, and INR was
routinely checked daily during the postoperative hospital
stay period, then weekly through the first postoperative
month, and subsequently on indication of our dedicated
anticoagulation outpatient clinic (by default once every
three or four weeks). For patients with bileaflet mechan-
ical prostheses in aortic position the target INR ranged
between 2.0 and 3.0 before 2000, and between 1.8 and
2.5 thereafter.
Follow-up
The method of follow-up for our retrospective studies,
in patients wearing mechanical valve prostheses has
been described in previous reports (2-5). Follow-up has
mainly been conducted on all hospital survivors during
our institutional ambulatory activities and was 98.3%
complete. Adverse events, with particular focus on
bleeding, transient ischemic attacks, reversible or non-
reversible ischemic neurologic deficits, are classified fol-
lowing the Guidelines for Reporting Morbidity and Mor-
tality After Cardiac Valvular Operations as proposed by
the Society of Thoracic Surgeons [6]. When appropriate,
an echocardiogram follows physical examination.
To the purpose of the present analysis, data regarding
the operation and the early postoperative period were
retrospectively collected by hospital charts and
outpatient charts review, while follow-up data of hospi-
tal survivors derived mainly from our ambulatorial activ-
ities. The anticoagulation results, the data regarding
every complication possibly occurred and the scores
obtained at the SF-36 test for each patient were retro-
spectively inserted in an electronic database. INR varia-
bility (percentage of values outside the therapeutic
range) was calculated for each patient. All patients had
been seen at our outpatient clinic and/or followed-up by
telephone interview at least once since their discharge.
In particular, of the 438 hospital survivors, 328 (74.8%)
used to perform periodic controls at our ambulatory
(median of the maximum number of visits per year: 13,
range 12-25) and by June 2010 had already undergone a
recent visit (within the last 2 months). Of the other 110
patients (48 of whom used to attend satellite regional
anticoagulation centers that follow the same anticoagu-
lation protocol as ours), 84.6% were contacted by tele-
phone and then visited in our outpatient clinic to
update their follow-up. Thus, all in all, 318 hospital sur-
vivors were visited between April and June 2010 (96.9%
completeness of clinical follow-up).
Quality of Life Assessment
Follow-up included the assessment of perceived QOL
through the SF-36 [7], which has an established validity
and reliability [8]. The SF-36 questionnaire consists of
36 items grouped into eight domains:
￿ Physical Functioning (10 items) indicates level of
limitations in lifting, bending, kneeling, or walking
moderate distance.
￿ Role-physical (4 items) measures the degree in per-
forming of usual activities for age and social status,
such as job and community activities.
￿ Bodily Pain (2 items) represents the intensity, fre-
quency, and duration of bodily pain and limitations
in normal activities due to pain.
￿ General Health (6 items) is a measurement of per-
ceived overall health, including past and present
health.
￿ Vitality (4 items) measures feeling of energy, fati-
gue, and tiredness.
￿ Social Functioning (2 items) indicates ability to
develop and maintain mature social relationships.
￿ Role-emotional (3 items) measures personal feeling
of job performance at work or other activities.
￿ Mental Health (5 items) measures the emotional,
cognitive, and intellectual status of the patient.
All SF-36 domains are scaled from 0 to 100 points,
with higher scores indicating better-perceived QOL. The
mean scores obtained by the two study groups were
compared with those of the general Italian population
matched for age and sex.
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Continuous data were expressed as mean ± SD, and
compared using Student’s t test. Discrete variables were
compared using the chi-square test. Factors significantly
associated with adverse outcomes were introduced in a
multivariate logistic regression model to identify inde-
pendent predictors of hospital and long-term mortality.
Kaplan-Meier actuarial analyses of survival rates and of
freedom from valve-related complications were per-
formed. Scores obtained in each of the 8 domains of the
SF-36 test were compared with those reported [6] for
the age and sex-matched Italian population. A difference
yielding a p value of < 0.05 was considered statistically
significant. SPSS statistical software, version 13.0 was
employed for analysis.
Kaplan-Meier actuarial analyses of survival rates and
incidence of valve-related complications were
performed..
Actuarial rates are expressed as percentage of patients
who were event free.
Continuous data are reported as mean ± SD. All sta-
tistical analyses were performed with SPSS version 13.0
Results
Preoperative characteristics of the study population are
reported in Table 1. Study population was composed by
520 patients who underwent AVR for aortic valve steno-
sis. Of them 114 (21.9%) patients received associated
CABG to AVR (group B), while 406 (78.07%) received
isolated mechanical valve implantation in aortic position
(group A).
All patients were older than 70 years with a mean age
of 74.2 ± 3.6, 74.3 ± 3.6 in group A versus 74 ± 3.3 in
group B (p = 0.33).
At time of surgery 47 patients (9,1%) were in New
York Heart Association functional class IV, 338 (65%)
were in class III, the remaining 135 (25,9%) were in
class II. No difference was evident in proportion of
NYHA class comparing the two groups of study
population.
In-hospital death occurred in 46 patients (9.5%), 29
(7.8%) patients in group A and 17 (15.2%) in group B (p
= 0.019) with statistical difference at univariate analisys
(p = 0.027). Multivariate analysis on the contrary did
not reveal associated CABG as a predictor of hospital
mortality. The causes of death were perioperative acute
myocardial infarction in 9 cases (19.6%), low output syn-
drome in 5 patients (10.9%), stroke in 2 (4.3%), pulmon-
ary infection in 16 (34.8%), multi-organ failure in 10
(21.8%), malignant arrhythmia in 2 (4.3%), visceral ische-
mia in 2 (4.3%).
Mean follow-up was 4.2 ± 3.3 years (median 3.2 years)
and ranged from 6 months to 17.7 years (2016.95 pts/
years). During the follow-up time, 36 late deaths
occurred (7.6% of hospital survivors). Causes of death in
the follow-up were sudden death in 4 patients, myocar-
dial infarction in 1, intracranial hemorrhage in 1,
ischemic stroke in 1, neoplasm in 9, respiratory failure
in 8, cirrhosis in 3, dementia in 2, postoperative death
(after re-operation for prosthetic endocarditis) in 1, old-
ness and progressive general delay in 6. Overall actuarial
survival (including hospital mortality) was 88.5% ± 0.015
at 1 year, 81.9% ± 0.02 at 5 years, 76.6% ± 0.032 at 10
years. Ten-year survival was 77% ± 0.034 in Group A,
77.8% ± 0.045 in Group B (log rank = 0.2). A multivari-
ate analysis for long-term mortality did not reveal that
associated CABG was a predictor. Dialysis-dependent
renal failure was found as predictor of long term mor-
tality (OR 22; IC 4.4-110).
Anticoagulation-related and valve-related complications
During the follow-up period, the mean INR in this ser-
ies was 2.15 ± 0.16. Four major hemorrhagic events
occurred in 4 patients in the follow-up, including 2
Table 1 Preoperative characteristics of the study population.
Group A (406 pts) Group B (114 pts) p
Age 74.3 ± 3.6 74 ± 3.3 0.33
Sex (male) 173 (42.6%) 73 (64%) 0.0001
Class NYHA
IV 36 (9%) 11 (9.6%) 0.9
III 264 (65%) 74 (64.9%) 0.93
II 106 (26.1%) 29 (25.4%) 0.97
Hypertension 258 (63.5%) 71 (62.3%) 0.9
Chronic Obstructive Pulmonary Disease 87 (21.4%) 25 (21.9%) 0.98
Diabetes 79 (19.4%) 53 (46.8%) 0.0001
Chronic Renal Insufficiency 13 (3.2%) 8 (7%) 0.12
Atrial fibrillation 31 (7.6%) 10 (8.7%) 0.85
EuroScore logistic 7.52% ± 2.18 10.4% ± 3.4 0.0001
Vicchio et al. Journal of Cardiothoracic Surgery 2012, 7:13
http://www.cardiothoracicsurgery.org/content/7/1/13
Page 3 of 6cases of gastric bleeding (requiring surgery in 1 cases), 1
intracranial bleeding and 1 hematuria requiring hospita-
lization. Freedom from bleeding was 99.7% ± 0.003 at 1
year, 98.4% ± 0.008 at 5 and 96.9% ± 0.013 at 10 years.
Thromboembolic complications were observed in 3
patients: 1 ischemic stroke, 1 transient ischemic attack,
1 pulmonary embolism. Freedom from thromboembo-
lism was 99.7% ± 0.003 at 1 year, 99% ± 0.006 at 5 years
and 10 years.
Freedom from valve-related complications was 99.1%
± 0.005 at 1 years, 95.5% ± 0.013 at 5 and 94.7% ±
0.015 at 10 years. Ten-years freedom from valve-related
complication in the two subgroups did not show signifi-
cant difference (88.5% ± 0.063 in Group A, 91.9% ±
0.034 in Group B p = 0.26).
Quality of life results
All survivors answered the SF-36 questionnaire, and
there was no statistical difference in the scores obtained
in the two groups of the study population evaluating the
eight domains of the test. When compared with the
mean scores of the general Italian population matched
for age and sex, significantly higher scores were reached
by the two groups of the study population, with a p value
of < 0.001 in all domains. The scores obtained in the var-
ious domains for Group A, Group B and the general Ita-
lian population of Elderly were reported in Figure 1.
Discussion
The increased life expectancy of the Western population
in the last decades [9], associated with the improve-
ments in surgical standards and postoperative care, has
progressively expanded the age criteria of operability in
cardiac surgery [10]. As a consequence, the number of
elderly patients undergoing heart valve replacement has
been increasing, as well as their long-term survival. In
particular it has been rising the number of elderly
requiring AVR for severe calcific aortic valve stenosis,
which is a tipical disease of the older age.
The growing number of elderly referring to cardiac
surgical procedures has increased the attention on the
outcomes in this subset of patients and on the predic-
tion of long term survival.
When coronary artery obstructive disease is associated
to severe aortic valve calcific stenosis in the elderly
patients, CABG has to be combined to AVR.
Many clinical series investigating determinants of early
mortality following AVR, identified associated CABG as
independent predictor [11,12].
The 4
th European Association for Cardiothoracic Sur-
gery Adult Cardiac Surgery 2010 database reports that
overall mortality for isolated valve surgery is 3.7% while
for CABG combined with valve procedures it increases
to 6.2% [13].
Also in our series the association of CABG to AVR
demonstrated to increase hospital mortality (15.2% vs
7.8%) and univariate analysis revealed CABG as a pre-
dictor of early death.
A tt h es a m et i m eC A B Ga s s o c i a t e dt oA V Ri m p r o v e s
long term survival with acceptable morbidity and mor-
tality in elderly patients [12].
This data is confirmed by several reports: on the arena
of long term survival, Akins et al. Reported the survival
of patient following CABG is essentially equivalent to
that of age and gender matched cohorts from the gen-
eral population up to 5 years after surgery [14]. Sergeant
a n da s s o c i a t e dd e m o n s t r a t e dt h a tt h ea c t u a r i a ls u r v i v a l
of elderly coronary artery by-pass patients came actually
be better than that predicted for the general population
out to 10 years, whereas survival of the young coronary
by-pass patients is poorer than a comparable cohort
from the general population [15].
Findings of our study confirmed that long term mor-
tality and morbidity are not significantly different when
CABG is associated to AVR in elderly patients suffering
of severe calcified aortic valve stenosis and obstructive
coronary disease.
In order to extend the investigation to long term qual-
ity of life, the SF-36 test was applied in both groups of
patients. Group A and Group B showed similar scores
in QOL that resulted better of age and gender matched
population. The increased life expectancy results in a
growing necessity to maintain maximum functioning
and independent lifestyle. Health-related QOL is a mul-
tidimensional concept based on the patient’s perception
of his or her health and integrates not only physical
functioning but also psychologic status and social
dimensions. Standardized questionnaires, especially
those self-completed by patients, are a practical,
Figure 1 SF-36 scores obtained in the 8 domains of the
questionnaire in the Group A, in the Group B and in the Italian
age and sex-matched population.
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There is a growing interest in the use of health status to
evaluate clinical strategies, and because improvement in
QOL is considered to be one of the principal goals of
valve surgery [16], methods of QOL assessment are
increasingly adopted in the clinical research in this field.
From reports on postoperative QOL, patients deciding
among treatment options may value information about
the change in QOL that they can expect after valve sur-
gery. Therefore, QOL needs to be assessed in large and
well-defined patient subsets, and it is particularly impor-
tant to evaluate QOL in elderly patients, who have a
higher prevalence of comorbidity, a more severe surgical
stress, and a higher risk of postoperative complications,
all factors that may hinder improvement in QOL.
Although numerous methods exist for evaluating QOL
of patients [17], the validated SF-36 questionnaire [8] is
comprehensive yet concise, can be completed in 10 to
15 minutes, and can be administered in person, by
phone, or by mail, even in elderly patients [7].
Investigators focusing on long-term outcomes after
AVR in octogenarians have reported a positive impact
on QOL [18]. Sundt and colleagues described postopera-
tive SF-36 scores in AVR patients aged older than 80
years that were comparable with those of the general
e l d e r l yp o p u l a t i o n[ 1 9 ] .I nt h ep r e s e n ts t u d y ,w e
obtained in seven of the eight domains of the test signif-
icantly higher scores than the mean general Italian
population matched for age and sex.
When interpreting this result, it should be considered
that more than 70% of the patients in our study popula-
tion were in NYHA functional class III to IV before the
operation, so a high percentage of our patients experi-
enced, for a various period of time, a moderate to severe
limitation to their daily activity. Symptom relief and the
return to previous lifestyle can probably increase the
perception of a patient’s own health status. Similarly,
the Italian general population scores were lower than in
our study population because the healthy elderly are
prone to compare their current physical and psychologic
performances with their youth, with a perceived differ-
ence caused by the effects of the aging process itself.
Other authors in series of AVR [20] found similar differ-
ences between the previously operated on elderly and
the age-matched control population, in particular for
what concerns the social functioning and emotional
domains.
Associated CABG determines an increase of hospital
mortality in the elderly undergoing aortic valve replace-
ment; at the same time survivors did not show differ-
ences in long-term outcome and quality of life
according to the presence of associated CABG.
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